BDBM50263103 (2-(2,6-difluorophenyl)-1-(3-ethoxyphenyl)-1H-imidazol-4-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone::CHEMBL473457

SMILES CCOc1cccc(c1)-n1cc(nc1-c1c(F)cccc1F)C(=O)N1CCN(CC1)c1ccc2ccccc2c1

InChI Key InChIKey=BNCVYQGQRCUXJK-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50263103   

TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263103((2-(2,6-difluorophenyl)-1-(3-ethoxyphenyl)-1H-imid...)
Affinity DataIC50:  1.90nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263103((2-(2,6-difluorophenyl)-1-(3-ethoxyphenyl)-1H-imid...)
Affinity DataEC50:  4.40nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed